title: [Pigmented lesions secondary to indapamide].
authors.forename: F
authors.initials: F
authors.lastname: Roy-Péaud
authors.forename: M C
authors.initials: MC
authors.lastname: Pérault-Pochat
authors.forename: M
authors.initials: M
authors.lastname: Paccalin
authors.forename: G
authors.initials: G
authors.lastname: Le Moal
authors.forename: C
authors.initials: C
authors.lastname: Landron
authors.forename: L
authors.initials: L
authors.lastname: Juhel
authors.forename: P
authors.initials: P
authors.lastname: Roblot
authors.forename: B
authors.initials: B
authors.lastname: Becq-Giraudon
mesh_terms: D000368:Aged; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005145:Face / Q000473:pathology; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D007190:Indapamide / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male
chemical_list: D000959:Antihypertensive Agents; D007190:Indapamide